IL163577A0 - Interferon beta-like molecules for treatment of stroke - Google Patents

Interferon beta-like molecules for treatment of stroke

Info

Publication number
IL163577A0
IL163577A0 IL16357703A IL16357703A IL163577A0 IL 163577 A0 IL163577 A0 IL 163577A0 IL 16357703 A IL16357703 A IL 16357703A IL 16357703 A IL16357703 A IL 16357703A IL 163577 A0 IL163577 A0 IL 163577A0
Authority
IL
Israel
Prior art keywords
stroke
molecules
treatment
interferon beta
interferon
Prior art date
Application number
IL16357703A
Other languages
English (en)
Original Assignee
Maxygen Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Aps filed Critical Maxygen Aps
Publication of IL163577A0 publication Critical patent/IL163577A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16357703A 2002-03-12 2003-02-28 Interferon beta-like molecules for treatment of stroke IL163577A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200200371 2002-03-12
PCT/DK2003/000127 WO2003075944A2 (fr) 2002-03-12 2003-02-28 Molecules de type interferon beta destinees au traitement des accidents vasculaires cerebraux

Publications (1)

Publication Number Publication Date
IL163577A0 true IL163577A0 (en) 2005-12-18

Family

ID=27798724

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16357703A IL163577A0 (en) 2002-03-12 2003-02-28 Interferon beta-like molecules for treatment of stroke

Country Status (10)

Country Link
US (1) US20060083715A1 (fr)
EP (1) EP1487478A2 (fr)
JP (1) JP2005519946A (fr)
KR (1) KR20040104504A (fr)
AR (1) AR038900A1 (fr)
AU (1) AU2003214019A1 (fr)
CA (1) CA2477577A1 (fr)
IL (1) IL163577A0 (fr)
MX (1) MXPA04008798A (fr)
WO (1) WO2003075944A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084933A1 (fr) 2003-03-28 2004-10-07 Faron Pharmaceuticals Oy Elevation du niveau d'adenosine par l'expression induite par cytokine de cd73
KR20070085227A (ko) * 2004-08-09 2007-08-27 앨리오스 바이오파마 인크. 합성 초글리코실화, 프로테아제 저항성 폴리펩티드 변이체,경구 제제 및 이를 이용한 방법
US7597884B2 (en) * 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
CN101282990B (zh) * 2005-08-26 2013-04-03 阿雷斯贸易股份有限公司 糖基化干扰素-β的制备方法
FI20051003A0 (fi) * 2005-10-07 2005-10-07 Faron Pharmaceuticals Oy Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi
AU2008247815B2 (en) 2007-05-02 2012-09-06 Ambrx, Inc. Modified interferon beta polypeptides and their uses
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
BR112014007766B1 (pt) * 2011-10-01 2022-05-10 Glytech, Inc Polipeptídeo glicosilado, método para fabricação do mesmo e composição farmacêutica
AU2014245917B2 (en) 2013-03-29 2017-09-28 Glytech, Inc. Polypeptide having sialylated sugar chains attached thereto
EP3215178A4 (fr) * 2014-11-06 2018-07-25 Yeda Research and Development Co. Ltd Traitement de troubles inflammatoires de snc

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2210622A1 (fr) * 1995-11-17 1997-05-29 Toray Industries, Inc. Protection des cellules endotheliales
JPH09151137A (ja) * 1995-12-01 1997-06-10 Toray Ind Inc 平滑筋細胞増殖抑制剤
EP1372702B1 (fr) * 2001-04-03 2007-07-18 U-Cytech B.V. Traitement de l'insuffisance circulatoire liee a l'hypoxie/ischemie avec de l'interferon-beta
US6887462B2 (en) * 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
WO2002089828A2 (fr) * 2001-05-04 2002-11-14 Institute Of Molecular And Cell Biology Traitement de l'ischemie

Also Published As

Publication number Publication date
WO2003075944A2 (fr) 2003-09-18
WO2003075944A3 (fr) 2004-03-18
MXPA04008798A (es) 2004-11-26
CA2477577A1 (fr) 2003-09-18
AR038900A1 (es) 2005-02-02
AU2003214019A1 (en) 2003-09-22
KR20040104504A (ko) 2004-12-10
JP2005519946A (ja) 2005-07-07
EP1487478A2 (fr) 2004-12-22
US20060083715A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
HK1074784A1 (en) Treatment of mucositis
AU2003236991A8 (en) Representations of processes
HK1097704A1 (en) Process for producing protein hydrolysate and protein hydrolysate
ZA200600025B (en) Methods and compositions for interferon therapy
AU2003254641A8 (en) Interferon beta-like molecules for treatment of cancer
IL152865A0 (en) Peristalic pump
IL163577A0 (en) Interferon beta-like molecules for treatment of stroke
EP1701735A4 (fr) Procedes et compositions a utiliser pour le traitement des diabetes
EP1575606A4 (fr) Traitement de l'arthrose
IL172184A0 (en) Interferon gamma - like protein
GB0306309D0 (en) Method of treatment
GB0302572D0 (en) Method of treatment
EP1668146A4 (fr) Populations homogenes de molecules
GB2392746B (en) Comparison of molecules using field points
IL171945A0 (en) Iodopyrazolyl carboxanilides
GB0221157D0 (en) Novel treatment
GB0217493D0 (en) Novel methods of treatment
GB0223153D0 (en) Prestressing of components
GB0219835D0 (en) Treatment of anemia
GB0311158D0 (en) Respiratory interferon process
TW558019U (en) Structure of illumination apparatus
GB0304021D0 (en) Treatment of hypertension
GB0229986D0 (en) Treatment of materials
GB0311622D0 (en) Ischaemic stroke treatment
GB0313022D0 (en) Ischaemic stroke treatment